Fig. 4From: Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatmentKaplan–Meier curves of PFS and OS in KRAS/NRAS/BRAF WT patients according to four different first-line therapiesBack to article page